Crossmark

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s40121-023-00811-3

Published Online: 2023-05-03

Published Print: 2023-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tai, Wei-Chen

Yang, Shih-Cheng

Yao, Chih-Chien

Wu, Cheng-Kun

Liu, An-Che

Lee, Chen-Hsiang

Kuo, Yuan-Hung

Chuah, Seng-Kee https://orcid.org/0000-0002-8934-3223
Liang, Chih-Ming
Funding

Funding for this research was provided by:

Kaohsiung Chang Gung Memorial Hospital (CMRPG8H0631)
License Information

Text and Data Mining valid from 2023-05-01

Version of Record valid from 2023-05-03
More Information

Article History

Received: 6 March 2023

Accepted: 14 April 2023

First Online: 3 May 2023

Document is current

Any future updates will be listed below